Rituximab, Methotrexate, and Thiotepa (R-MT) Induction Followed by Etoposide and Cytarabine (EA) Consolidation
PCNSL-RMTEA
Unknown small_molecule active
Quick answer
Rituximab, Methotrexate, and Thiotepa (R-MT) Induction Followed by Etoposide and Cytarabine (EA) Consolidation for Primary Central Nervous System Lymphoma (PCNSL) is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Primary Central Nervous System Lymphoma (PCNSL)
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active